- Market Realist•12 hours ago
Boston Scientific (BSX) is consistently working towards gaining higher market share in the attractive TAVR (transcatheter aortic valve replacement) market in Europe.
- Market Realist•14 hours ago
On September 27, 2016, Boston Scientific (BSX) announced the acquisition of EndoChoice Holdings for $210 million.
Boston Scientific Corporation (BSX)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||23.75 x 9100|
|Ask||23.76 x 36900|
|Day's Range||23.57 - 23.77|
|52wk Range||15.67 - 24.79|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-92.77|
|Avg Vol (3m)||8,219,089|
|Dividend & Yield||N/A (N/A)|